ArticlePharmaceuticals (Basel, Switzerland)2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.
Juliana Salazar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.